Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. DexCom, Inc.
  6. Financials
    DXCM   US2521311074

DEXCOM, INC.

(DXCM)
  Report
Delayed Nasdaq  -  05/20 04:00:01 pm EDT
321.23 USD   +1.62%
05/20DEXCOM INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/17Citigroup Adjusts DexCom's Price Target to $525 From $630, Reiterates Buy Rating
MT
05/11TRANSCRIPT : DexCom, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 02:40 PM
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 20 02135 50352 04231 521--
Enterprise Value (EV)1 20 63436 35352 69231 45731 41931 058
P/E ratio 199x73,1x346x86,4x73,3x54,6x
Yield ------
Capitalization / Revenue 13,6x18,4x21,3x10,8x9,01x7,53x
EV / Revenue 14,0x18,9x21,5x10,8x8,98x7,42x
EV / EBITDA 98,3x94,1x111x44,3x34,3x25,5x
Price to Book 22,7x21,1x23,1x11,8x10,0x8,89x
Nbr of stocks (in thousands) 91 52996 02896 92298 126--
Reference price (USD) 219370537321321321
Announcement Date 02/13/202002/11/202102/10/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 1 4761 9272 4492 9173 5004 184
EBITDA1 2103874737109161 216
Operating profit (EBIT)1 161319371462640848
Operating Margin 10,9%16,6%15,1%15,8%18,3%20,3%
Pre-Tax Profit (EBT)1 104225174404584795
Net income1 101494155380452612
Net margin 6,85%25,6%6,32%13,0%12,9%14,6%
EPS2 1,105,061,553,724,385,89
Dividend per Share2 ------
Announcement Date 02/13/202002/11/202102/10/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 650698629695762828
EBITDA1 149131112176199217
Operating profit (EBIT)1 12499,050,3107140165
Operating Margin 19,0%14,2%8,00%15,5%18,4%19,9%
Pre-Tax Profit (EBT)1 90,7-14,736,197,7130156
Net income1 70,9-19,497,376,397,6117
Net margin 10,9%-2,78%15,5%11,0%12,8%14,1%
EPS2 0,71-0,200,930,730,931,19
Dividend per Share ------
Announcement Date 10/28/202102/10/202204/28/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 614850650---
Net Cash position1 ---63,8102463
Leverage (Debt / EBITDA) 2,92x2,20x1,38x-0,09x-0,11x-0,38x
Free Cash Flow1 13527753,3184402667
ROE (Net Profit / Equities) 22,0%22,3%13,1%13,9%16,8%19,1%
Shareholders' equity1 4592 2101 1832 7332 6953 205
ROA (Net Profit / Asset) 4,69%9,05%5,83%5,81%9,28%12,4%
Assets1 2 1565 4542 6556 5444 8754 950
Book Value Per Share2 9,6417,523,227,332,036,1
Cash Flow per Share2 3,414,884,424,796,687,65
Capex1 180199389333297317
Capex / Sales 12,2%10,3%15,9%11,4%8,48%7,58%
Announcement Date 02/13/202002/11/202102/10/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 31 520 993 457
Net sales (USD) 2 448 500 000
Number of employees 6 300
Sales / Employee (USD) 388 651
Free-Float 99,5%
Free-Float capitalization (USD) 31 360 399 171
Avg. Exchange 20 sessions (USD) 313 473 066
Average Daily Capital Traded 0,99%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA